IBSA Hyaluronic Acid
OSTEOARTHRITIS
Degenerative joint
disease

OSTEOARTHRITIS (OA) OR ARTHROSIS

WHAT ARTHROSIS IS

WHAT ARTHROSIS IS

Osteoarthritis (or arthrosis) is a degenerative disease of the joints associated with the progressive deterioration and wearing away of the cartilage and disorders in the nearby structures, especially the bone.
WHO SUFFERS FROM IT

WHO SUFFERS FROM IT

There are 240 million people suffering from systematic Osteoarthritis. In the UK there are over 10 million people suffering from arthritis. This number is likely to increase due to progressively aging of the population. Moreover, it can also be caused by frequent stimulation and mechanical strain on the joints, thus affecting even athletic or highly active individuals.
FORMS OF OSTEOARTHRITIS

FORMS OF OSTEOARTHRITIS

Osteoarthritis can develop in any number of joints, but most commonly affects the knees, hands, and hips.
RISK FACTORS

RISK FACTORS

Two types of risk factors are generally distinguished during the development of osteoarthritis: [1]. Modifiable risk factors which are preventable and related to lifestyle including: Excess weight and Obesity Trauma and joint injuries Occupation related activities [2]. Non-modifiable risk factors including: Genetic predisposition Female gender Advancing age
SIGNS AND SYMPTOMS

SIGNS AND SYMPTOMS

The basic clinical signs of osteoarthritis are pain, stiffness and progressive functional limitation, which may be associated with varying degrees of deformity.
DIAGNOSIS

DIAGNOSIS

It is important to seek advice from a Healthcare Professional as soon as the initial symptoms appear. The diagnosis of osteoarthritis is based on determination of the patient’s clinical history and assessment of the symptoms (anamnesis), accompanied by an appropriate objective examination (the actual consultation). This then requires an X-ray examination. The X-ray image will show the main signs of osteoarthritis: the presence of osteophytes, i.e. the growth of bone tissue localised on the bone surface, and a reduction in the joint space.
TREATMENT

TREATMENT

Osteoarthritis is a degenerative disease with painful exacerbations. Treatment must therefore simultaneously control the pain and slow down the process of joint degeneration. Today, new treatments are available that can counteract cartilage deficits, enhance the spontaneous repair processes and effectively control pain. Depending on the extent and location of the disease, your Healthcare Professional will suggest the best course of treatment and make some suggestions as to how to improve your “lifestyle”, such as losing weight if necessary, and doing light aerobic exercise (swimming, aqua aerobics, cycling), which does not involve strain on the painful joint.

THERAPEUTIC APPROACH

The ESCEO guidelines propose a scheme based on various treatment scenarios.
Depending on whether or not the symptoms are persistent, these guidelines suggest approaches that become progressively more invasive, beginning with non-pharmacological treatments that are increasingly gaining ground (physiotherapy, infiltrative therapy using hyaluronic acid, etc.), moving onto more structured pharmacological treatments (chondro-protectors, anti-inflammatories, weak opioids); and ultimately to surgical procedures or even prosthetic replacement where necessary.

STEP 1

Raggruppa 647@2x

NON-PHARMACOLOGICAL TREATMENT

  • Aerobic physical exercise
  • Losing weight (if necessary)
  • Physiotherapy

PHARMACOLOGICAL TREATMENT

  • Chondroprotectors

STEP 2

Raggruppa 632@2x

NON-PHARMACOLOGICAL TREATMENT

  • Infiltrative therapy using hyaluronic acid

PHARMACOLOGICAL TREATMENT

  • Anti-inflammatories
  • Opioids

STEP 3

Raggruppa 567@2x

SURGERY

  • Arthroplasty

The information on the website is for information purposes only and is not to be considered a substitute for medical advice. Ask your doctor for more information.

SEVERITY OF SYMPTOMS

PRODUCTS

IBSA specialises in research and development, production and marketing of hyaluronic acid-based products.